<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pharmaceutical on FinanClub</title>
    <link>https://finan.club/tags/pharmaceutical/</link>
    <description>Recent content in Pharmaceutical on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 19 Jan 2024 09:04:15 +0000</lastBuildDate><atom:link href="https://finan.club/tags/pharmaceutical/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MRK</title>
      <link>https://finan.club/us/mrk/</link>
      <pubDate>Fri, 19 Jan 2024 09:04:15 +0000</pubDate>
      
      <guid>https://finan.club/us/mrk/</guid>
      <description>score:112
Chances: Merck&amp;rsquo;s stock price might be vulnerable to institutional stake FDA approval of Keytruda for cervical cancer is a significant opportunity for Merck Merck&amp;rsquo;s Animal Health division shows positive trend in wellbeing and mental health of U.S. veterinarians Risks: Several Merck insiders have sold their stock in the past year Competition in the GLP-1 obesity space could pose a risk to Merck&amp;rsquo;s market share Score:112 chances characters count - risks characters count = 112</description>
    </item>
    
    <item>
      <title>PFE</title>
      <link>https://finan.club/us/pfe/</link>
      <pubDate>Wed, 17 Jan 2024 09:06:02 +0000</pubDate>
      
      <guid>https://finan.club/us/pfe/</guid>
      <description>score:50
Chances: Pfizer CEO is &amp;lsquo;all in&amp;rsquo; on Pfizer stock, showing confidence in the company&amp;rsquo;s future Pharmaceutical executives from various companies are looking to break into the lucrative obesity market, indicating potential for industry growth Pfizer is receiving unsolicited mini-tender offers, suggesting interest from potential investors Risks: Pfizer&amp;rsquo;s best days might be behind it as demand for its COVID-19 products slows down Pfizer shares dropped more than 40% last year, indicating potential instability in the stock Legal battles against diversity and inclusion programs could impact Pfizer&amp;rsquo;s image and operations Score:50 chances characters count - risks characters count = 50</description>
    </item>
    
  </channel>
</rss>
